Ftse Mib
34.676,17
1,15%
DAX
19.254,97
1,03%
S&P 500
5.728,80
0,41%
NASDAQ
18.239,92
0,80%
Bitcoin
69.609,13
0,18%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CervoMed Inc (CRVO) CervoMed Inc (CRVO) Notizie

CervoMed Inc

CRVO
13,45
-0,20 (-1,47%)
02 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/10/202413:00EDGAR2Form 8-K - Current report
29/10/202413:00GLOBECervoMed to Deliver Oral Presentation at the 8th..
16/10/202414:00EDGAR2Form 8-K - Current report
15/10/202414:00GLOBECervoMed Announces Last Patient Last Visit in Phase 2b..
11/10/202414:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
10/10/202414:44EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/10/202423:12EDGAR2Form S-3 - Registration statement under Securities Act of..
03/10/202423:02EDGAR2Form POS AM - Post-Effective amendments for registration..
03/10/202422:21EDGAR2Form 8-K - Current report
02/10/202414:00GLOBECervoMed to Participate in 3rd Annual ROTH Healthcare..
01/10/202414:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/10/202414:00EDGAR2Form 8-K - Current report
26/9/202414:00GLOBECervoMed to Deliver Late-Breaking Oral Presentations at the..
27/8/202414:30GLOBECervoMed to Participate in Upcoming Investor Conferences
22/8/202414:00GLOBECervoMed Featured in Fortune for Advances in the Treatment..
12/8/202414:00GLOBECervoMed Reports Second Quarter 2024 Financial Results and..
30/7/202414:00GLOBECervoMed to Participate in The Canaccord Genuity 44th Annual..
29/7/202414:00GLOBECervoMed Announces Presentation at AAIC 2024 on Plasma..
17/7/202414:00GLOBECervoMed to Participate in the Emerging Growth Conference
11/7/202414:51GLOBECervoMed to Host Virtual KOL Event on Neflamapimod for..
24/6/202414:00GLOBECervoMed Announces Addition to Russell 2000® and Russell..
11/6/202414:00GLOBECervoMed Announces Completion of Enrollment in Phase 2b..
20/5/202414:00GLOBECervoMed to Appoint William Elder as Chief Financial Officer
15/5/202414:00GLOBECervoMed Reports First Quarter 2024 Financial Results and..
01/4/202414:00GLOBECervoMed Reports Fourth Quarter and Full Year 2023 Financial..
28/3/202413:30GLOBECervoMed Announces Up to $149.4 Million Private Placement..
05/3/202414:00GLOBECervoMed Announces Presentation of Biomarker Data from the..
21/2/202414:00GLOBECervoMed to Participate in the BIO CEO and Investor..
12/2/202414:00GLOBECervoMed Publishes Positive Results from AscenD-LB Phase 2a..
07/2/202414:30GLOBECervoMed Announces Appointment of Industry Leader Joshua..
05/2/202414:00GLOBECervoMed to Participate in the Emerging Growth Conference 67
05/1/202414:00GLOBECervoMed to Participate in the Emerging Growth Conference 66
13/11/202313:00PRNUSCervoMed Reports Third Quarter 2023 Financial Results and..
Apertura: 13,87 Min: 12,60 Max: 14,17
Chiusura: 13,65

La tua Cronologia

NASDAQ
CRVO
CervoMed
USOTC
NNAX
New Momentum (PK)
BIT
UC41KU
Unicredit Bank
BIT
HDLV
Invesco S & P 500 High D...
EU
FLOW
Flow Traders
USOTC
NGRRF
Nagarro (PK)
NYSE
HTG
Heritage Property Investment
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network